Syndo is a company that helps people suffering from a chronic disease to positively manage their illness. Syndo tries to achieve this by means of digital technology and personal lifestyle guidance.
Chronic diseases are responsible for about 80% of Belgium’s healthcare budget. The reason for this being that chronic diseases also require ‘chronic treatment’, in which the lifestyle of the patient has a crucial role in their therapy. However, it turns out that the traditional healthcare systems are ill-suited to support patients living with a chronic disease. As a result, there is commonly limited adaptation of the patient’s lifestyle to match their condition, resulting in many unnecessary re-hospitalisations leading to an increase in healthcare costs.
The uniqueness of Syndo is in the combined knowledge of three main domains:
Furthermore, Syndo is CE marked and has received a quality label from the Belgian government as one of the first mHealth applications.
The added value from TAG can been seen in several different key areas:
The TAG-consultants that we have worked with were always very well up to the job. They are very competent in the required areas of expertise and with their “can-do mentality” the work just got done.
Next year, Syndo will be included in the supplementary insurance package of Partenamut. This will accelerate the growth of our company.
Syndo is planning to further develop its digital offering by increasing the number of supported pathologies and improving the existing functionalities.
Last but not least, Syndo is interested in going international via expansion into France and Germany where there is already for mHealth applications support via government reimbursement.